Shkreli Martin

Director at Travere Therapeutics, Inc. · on record since Dec 28, 2012
Chief Executive Officer at Travere Therapeutics, Inc. · on record since Dec 28, 2012
10% owner at Travere Therapeutics, Inc. · on record since Dec 28, 2012
Fmr Officer Dir 10% Sharehldr at Travere Therapeutics, Inc. · on record since Nov 24, 2014
Director at HUMANIGEN, INC · on record since Nov 24, 2015
Chief Executive Officer at HUMANIGEN, INC · on record since Nov 24, 2015
10% owner at HUMANIGEN, INC · on record since Nov 24, 2015

Insider trading activity of Shkreli Martin

Transactions on record: 70; since Dec 26, 2012

Open-market buys: 47; $8.3M

Open-market sells: 10; $21.7M

Companies traded: 2; last filing Aug 29, 2016

Figures computed from official regulatory filings — .

Companies where Shkreli Martin has traded

HUMANIGEN, INC9 tx · $9.7M · Aug 29, 2016
Travere Therapeutics, Inc.61 tx · $22.9M · Nov 24, 2014

Track record of Shkreli Martin

Statistical track record

Free account

Open-market buys: 49

Last buy: Nov 24, 2015

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Shkreli Martin

Co-insiders of Shkreli Martin

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
HUMANIGEN, INCListing unverified	Aug 29, 2016	Sell	-309,723	3.10 USD	$960.1K		SEC
HUMANIGEN, INCListing unverified	Aug 29, 2016	Sell	-1,913,206	3.10 USD	$5.9M	Unusual size	SEC
HUMANIGEN, INCListing unverified	Nov 24, 2015	Buy	5,000	38.15 USD	$190.8K	conv 25Cluster	SEC
HUMANIGEN, INCListing unverified	Nov 23, 2015	Buy	5,000	18.88 USD	$94.4K	conv 25Cluster	SEC
HUMANIGEN, INCListing unverified	Nov 19, 2015	Buy	440,000	2.02 USD	$888.8K	conv 54ClusterUnusual size	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	7,000	2.43 USD	$17K	conv 7	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	606,677	1.93 USD	$1.2M	conv 59Unusual size	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	500,169	0.61 USD	$305.1K	conv 59First in 12mo	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	97,269	1.43 USD	$139.1K	conv 27First in 12mo	SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-254,975	9.19 USD	$2.3M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-134,354	8.23 USD	$1.1M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-252,847	8.41 USD	$2.1M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-100,000	10.23 USD	$1M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-100,000	9.41 USD	$941K		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	OtherD (derivative)	205,000	—	n/a (No price was disclosed in the filing)		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-329,824	8.54 USD	$2.8M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	OtherD (derivative)	123,000	—	n/a (No price was disclosed in the filing)		SEC
Travere Therapeutics, Inc.Listing on record	Oct 9, 2014	Buy	25,000	8.11 USD	$202.8K	conv 19	SEC
Travere Therapeutics, Inc.Listing on record	Oct 9, 2014	Other	332,980	—	n/a (No price was disclosed in the filing)		SEC
Travere Therapeutics, Inc.Listing on record	Oct 9, 2014	Sell	-300,000	0.01 USD	$3K		SEC
Travere Therapeutics, Inc.Listing on record	Oct 2, 2014	Buy	4,000	9.42 USD	$37.7K	conv 18	SEC
Travere Therapeutics, Inc.Listing on record	Sep 23, 2014	Buy	18,000	11.78 USD	$212K	conv 20	SEC
Travere Therapeutics, Inc.Listing on record	Sep 23, 2014	Buy	35,000	10.82 USD	$378.7K	conv 27	SEC
Travere Therapeutics, Inc.Listing on record	Sep 18, 2014	Buy	6,000	11.46 USD	$68.8K	conv 4	SEC
Travere Therapeutics, Inc.Listing on record	Sep 16, 2014	Buy	7,500	10.69 USD	$80.2K	conv 4	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
HUMANIGEN, INCListing unverified	Aug 29, 2016	Sell	-309,723	3.10 USD	$960.1K		SEC
HUMANIGEN, INCListing unverified	Aug 29, 2016	Sell	-1,913,206	3.10 USD	$5.9M	Unusual size	SEC
HUMANIGEN, INCListing unverified	Nov 24, 2015	Buy	5,000	38.15 USD	$190.8K	conv 25Cluster	SEC
HUMANIGEN, INCListing unverified	Nov 23, 2015	Buy	5,000	18.88 USD	$94.4K	conv 25Cluster	SEC
HUMANIGEN, INCListing unverified	Nov 19, 2015	Buy	440,000	2.02 USD	$888.8K	conv 54ClusterUnusual size	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	7,000	2.43 USD	$17K	conv 7	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	606,677	1.93 USD	$1.2M	conv 59Unusual size	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	500,169	0.61 USD	$305.1K	conv 59First in 12mo	SEC
HUMANIGEN, INCListing unverified	Nov 18, 2015	Buy	97,269	1.43 USD	$139.1K	conv 27First in 12mo	SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-254,975	9.19 USD	$2.3M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-134,354	8.23 USD	$1.1M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-252,847	8.41 USD	$2.1M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-100,000	10.23 USD	$1M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-100,000	9.41 USD	$941K		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	OtherD (derivative)	205,000	—	n/a (No price was disclosed in the filing)		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	Sell	-329,824	8.54 USD	$2.8M		SEC
Travere Therapeutics, Inc.Listing on record	Nov 24, 2014	OtherD (derivative)	123,000	—	n/a (No price was disclosed in the filing)		SEC
Travere Therapeutics, Inc.Listing on record	Oct 9, 2014	Buy	25,000	8.11 USD	$202.8K	conv 19	SEC
Travere Therapeutics, Inc.Listing on record	Oct 9, 2014	Other	332,980	—	n/a (No price was disclosed in the filing)		SEC
Travere Therapeutics, Inc.Listing on record	Oct 9, 2014	Sell	-300,000	0.01 USD	$3K		SEC
Travere Therapeutics, Inc.Listing on record	Oct 2, 2014	Buy	4,000	9.42 USD	$37.7K	conv 18	SEC
Travere Therapeutics, Inc.Listing on record	Sep 23, 2014	Buy	18,000	11.78 USD	$212K	conv 20	SEC
Travere Therapeutics, Inc.Listing on record	Sep 23, 2014	Buy	35,000	10.82 USD	$378.7K	conv 27	SEC
Travere Therapeutics, Inc.Listing on record	Sep 18, 2014	Buy	6,000	11.46 USD	$68.8K	conv 4	SEC
Travere Therapeutics, Inc.Listing on record	Sep 16, 2014	Buy	7,500	10.69 USD	$80.2K	conv 4	SEC